Press page

Welcome to the official press page of Sanity Group!
All relevant contents for media representatives in one place.

Press Contact

For all kind of media inquiries

Mr Thilo Grösch

Head of Public Relations | Press Officer

Email: thilo.groesch@sanitygroup.com | presse@sanitygroup.com

Phone: +49 30 80093764

For marketing/advertising or any other inquiries please contact: info@sanitygroup.com

Sanity Group GmbH
Jägerstraße 28-31 | 10117 Berlin | Germany

Contact for all kind of media inquiries

Mr Thilo Grösch

Head of Public Relations | Press Officer

Email: thilo.groesch@sanitygroup.com | presse@sanitygroup.com

Phone: +49 30 80093764

For marketing/advertising or any other inquiries please contact: info@sanitygroup.com

Address
Headquarter

Sanity Group | Jägerstr. 28-31 | 10117 Berlin | Germany

About Sanity Group

The Berlin-based health and life science company Sanity Group aims to improve people’s quality of life through the use of cannabinoids and the utilization of the endocannabinoid system. The focus is on pharmaceuticals (medical cannabis; finished pharmaceuticals) and medical products on the one hand, and cannabinoid-based consumer goods on the other. Sanity Group, founded in Berlin in 2018 by Finn Age Hänsel and Fabian Friede, is supported financially and strategically by investors such as Casa Verde Capital (Snoop Dogg), Navy Capital, Redalpine, HV Capital, Calyx, Cherry Ventures, Bitburger Ventures, SOJE Capital, and various business angels and celebrities such as Will.i.am (Black Eyed Peas), Scooter Braun, Hollywood actor Alyssa Milano and German soccer player Mario Götze.

The Berlin-based health and life science company Sanity Group aims to improve people’s quality of life through the use of cannabinoids and the utilization of the endocannabinoid system. The focus is on pharmaceuticals (medical cannabis; finished pharmaceuticals) and medical products on the one hand, and cannabinoid-based consumer goods on the other.

Sanity Group, founded in Berlin in 2018 by Finn Age Hänsel and Fabian Friede, is supported financially and strategically by investors such as Casa Verde Capital (Snoop Dogg), Navy Capital, Redalpine, HV Capital, Calyx, Cherry Ventures, Bitburger Ventures, SOJE Capital, and various business angels and celebrities such as Will.i.am (Black Eyed Peas), Scooter Braun, Hollywood actor Alyssa Milano and German soccer player Mario Götze.

What we do:

Medical & Pharma

Sanity Group’s medical business, including medical cannabis brands Vayamed and AVAAY Medical, and subsidiaries Belfry Medical (medical products & digital applications) and Endosane Pharmaceuticals (finished pharmaceuticals).

Extraction & Processing

Near Frankfurt am Main, Germany, Sanity Group operates a cannabis extract production and processing facility with laboratory.

Consumer Health

Sanity Group’s Consumer business with the brands VAAY (wellbeing) and This Place (functional natural cosmetics); further brands are planned.

2018

Sanity Group was founded by Finn Hänsel (CEO) and Fabian Friede (now works as a consultant)

Berlin

is the location of our headquarter; near Frankfurt am Main is our extraction & processing facility located

60+ Mio $

Total investment (after Series A funding round); Europe’s best-funded cannabis company

120+

Employees from over 15 different nations

50/50

Balanced gender ratio in the team

34,2 y

ø Average age of all employees

“Unfortunately, Cannabis still has very often a negative stigma attached to it. We want to give the plant a new chance, because what people associate with it is based on old prejudices. It’s important to us to actively contribute to education and knowledge transfer. This also involves showing decision-makers the differences between cannabis as a medicine, agricultural substance and lifestyle product. It’s important to understand the full potential of the plant – that’s what we’re working for, to bring cannabis back to the center of European society.”

– Finn Hänsel
Founder & Managing Director, Sanity Group

Downloads & pictures

Press pictures & Logo | Media kit | Speaker’s Profiles

Media center:
Pictures & Logo

Download portraits of our founders & management and press images in high-res and web optimized resolution.

Media kit

All information about Sanity Group in our digital press kit (PDF). Including factsheet, quotes and portrait (only available in German!).

Speaker's
Profiles

Short biographies & careers of Sanity Group founders Finn Hänsel and Fabian Friede (PDF) in German & English.

Latest News

German Cannabis company Sanity Group announces $37.6 Million Series B funding round

Leading German cannabis company Sanity Group announced today a $37.6M Series B financing round – Europe’s largest cannabis investment round to date. The funding round was led by BAT Group* with ongoing commitment from existing Sanity Group investors such as Redalpine and Casa Verde Capital and brings total funds raised by the company to over $100M.

Read more

Portugal, South Africa and Canada: Sanity Group strengthens and diversifies its global partner network

Berlin-based Sanity Group has signed new, exclusive supply agreements for medical cannabis with partners from Portugal, South Africa and Canada, securing further exclusive rights to around 20 high-THC cannabis flos from selected cultivars with a minimum volume of three tons per year for the brands Vayamed and AVAAY Medical. Deliveries are already scheduled to start at the end of the third quarter and beginning of the fourth quarter of 2022. In addition, further important strategic partnerships have been signed.

Read more

Sanity Group has expanded its management team

Berlin-based health and life science company Sanity Group has expanded its management team around CEO Finn Hänsel: Dr. Konstantin Rutz is the new Managing Director of the Group’s Medical division, Laura Simonow is Managing Director of the Consumer divison Sanity Care. The management team has also been broadened at Group level.

Read more

Vayamed Cannakits®: Innovative cannabis formulation kits enable new forms of application for an expanded therapy spectrum – experienced therapists sought for clinical support survey

Berlin-based medical cannabis specialist Vayamed is launching a formulation innovation designed to open up new possibilities in cannabis therapy: The Vayamed Cannakits® are special formulation kits based on an innovative two-syringe technology and contain all ingredients for the standardized production of cannabinoid-based new dosage forms in pharmacies. The first version of the Vayamed Cannakits®, which is available at pharmacies now, is especially designed for doctors with cannabis therapy experience who would like to use the product for selected patients in individual therapeutic trials within their own therapeutic jurisdiction.

Read more

Subscribe to press releases

We are happy to provide journalists, bloggers and media representatives with relevant information about Sanity Group on a regular basis. Subscribe to our press distribution list to receive our press releases directly in the future.

We would also be pleased if you keep us informed about publications and send us a specimen copy (gladly as a PDF) to presse@sanitygroup.com. Thank you very much!